T. Rowe Price Associates’s IMAX IMAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.3M Buy
954,825
+430,509
+82% +$16M ﹤0.01% 873
2025
Q4
$19.4M Buy
524,316
+1,613
+0.3% +$56.2K ﹤0.01% 1061
2025
Q3
$17.1M Buy
522,703
+2,245
+0.4% +$63.6K ﹤0.01% 1087
2025
Q2
$14.6M Buy
520,458
+2,144
+0.4% +$55.6K ﹤0.01% 1038
2025
Q1
$13.7M Buy
518,314
+501,453
+2,974% +$12.5M ﹤0.01% 1044
2024
Q4
$432K Buy
16,861
+2,776
+20% +$65.3K ﹤0.01% 2344
2024
Q3
$289K Buy
14,085
+670
+5% +$13.2K ﹤0.01% 2494
2024
Q2
$225K Buy
13,415
+333
+3% +$5.51K ﹤0.01% 2548
2024
Q1
$212K Buy
13,082
+2,153
+20% +$32.7K ﹤0.01% 2594
2023
Q4
$165K Buy
10,929
+806
+8% +$13.8K ﹤0.01% 2604
2023
Q3
$196K Buy
+10,123
New +$187K ﹤0.01% 2511

Other funds holding IMAX

T. Rowe Price Associates's IMAX Position: Q1 2026 in Review

T. Rowe Price Associates increased its IMAX (IMAX) stake by 82% in Q1 2026, buying an estimated $16M and bringing the position to 954,825 shares worth $36.3M. The position accounts for ﹤0.01% of the portfolio, ranked #873.

T. Rowe Price Associates first reported a position in IMAX in Q3 2023 and has held it in 11 quarters since. 254 funds tracked by Wall St. Rank hold IMAX as of Q1 2026.

  • T. Rowe Price Associates held 954,825 shares of IMAX worth $36.3M as of Q1 2026.
  • T. Rowe Price Associates bought 430,509 IMAX shares in Q1 2026, an estimated $16M.
  • IMAX made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #873 holding.
  • T. Rowe Price Associates first reported a position in IMAX in Q3 2023 and has held it in 11 quarters since.
  • 254 funds tracked by Wall St. Rank held IMAX as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.